ACTIGLIPT 20mg Tablet 10’s

Description

ACTIGLIPT 20mg Tablet is an oral antidiabetic combination medicine used to help improve blood sugar control in people with type 2 diabetes mellitus. it combines two different glucose-lowering agents that work through separate, complementary mechanisms, which can provide better overall glycemic control than either medicine alone in appropriate patients. this combination is generally prescribed along with diet modification, regular physical activity, and other lifestyle measures, because medicines for diabetes work best when combined with healthy daily habits.

remogliflozin etabonate belongs to the class of sodium-glucose co-transporter 2 (sglt2) inhibitors. it works mainly in the kidneys by reducing the reabsorption of glucose back into the bloodstream, allowing excess sugar to be removed in the urine. teneligliptin belongs to the class of dipeptidyl peptidase-4 (dpp-4) inhibitors. it helps the body increase insulin release after meals and reduces the liver? glucose production by preserving incretin hormones. together, these two actions help lower fasting and post-meal blood glucose levels in a more balanced way.

this medicine is intended for adults with type 2 diabetes who need additional blood sugar control, especially when single-drug therapy and lifestyle measures are not enough. it is not used to treat type 1 diabetes and is not a substitute for insulin in patients who require insulin therapy. because this combination can affect hydration, kidney function, and overall glucose balance, it should be used with proper medical supervision. a healthcare professional may choose this medicine when a patient may benefit from the dual action of urinary glucose excretion and incretin-based glucose control.

ACTIGLIPT 20mg Tablet may also support more stable day-to-day diabetes management by targeting both fasting and after-meal glucose excursions. however, it does not cure diabetes, and its effectiveness depends on adherence to prescribed treatment, routine monitoring, and ongoing clinical follow-up. patients should be alert to possible side effects, particularly urinary tract infections, genital infections, dehydration, and low blood sugar when used with other diabetes medicines that can cause hypoglycemia.

ingredients

• remogliflozin etabonate: this is the sglt2 inhibitor component of the combination. it lowers blood glucose by preventing the kidneys from reabsorbing filtered glucose, which increases urinary glucose excretion. this mechanism is especially helpful for reducing overall glucose burden without directly forcing the pancreas to produce more insulin. it may also lead to modest weight reduction in some patients because glucose calories are lost through the urine.
• teneligliptin: this is the dpp-4 inhibitor component. it helps preserve natural incretin hormones, which increase insulin secretion in a glucose-dependent manner and reduce glucagon release after meals. because its action depends on blood glucose levels, it generally has a low risk of causing hypoglycemia when used alone, but the risk can rise when combined with insulin or sulfonylureas.
• tablet excipients: the formulation may contain inactive ingredients that help with tablet stability, absorption, binding, and manufacturing. these do not provide therapeutic benefit but are important for product quality and delivery. patients with known allergies or intolerances should review the product-specific composition with a pharmacist or prescriber.

key uses

• type 2 diabetes mellitus: used to improve blood sugar control in adults with type 2 diabetes when diet, exercise, and one medicine alone do not adequately control glucose levels.
• combination glycemic management: helpful for patients who may benefit from two complementary mechanisms in a single tablet, which may improve adherence and simplify treatment compared with taking separate medicines.
• reduction of fasting and post-meal glucose: the teneligliptin component supports meal-related insulin release, while remogliflozin etabonate helps lower circulating glucose by increasing urinary sugar loss, together addressing different patterns of hyperglycemia.
• adjunct to lifestyle therapy: intended to be used alongside a diabetes-friendly diet, physical activity, weight management, and glucose monitoring as part of comprehensive disease control.

how to use

ACTIGLIPT 20mg Tablet should be taken exactly as directed by a healthcare professional. it is an oral medicine, usually swallowed with water, and may be taken with or without food depending on the product instructions and patient tolerance. consistency is important, so it is generally best to take it at the same time each day to support routine adherence and stable diabetes management. the tablet should not be split, crushed, or chewed unless a pharmacist or prescriber specifically advises that it is appropriate for the exact formulation being used.

because this is a prescription diabetes medicine, regular monitoring of blood glucose is important. your doctor may also periodically check kidney function, electrolytes, and overall response to treatment, especially if you are older, dehydrated, taking diuretics, or have a history of renal impairment. patients should continue following their meal plan and exercise routine, as medicine alone is usually not enough to control type 2 diabetes effectively. if you are uncertain whether a dose should be taken with food, how to coordinate it with other diabetes medicines, or how to monitor for side effects, consult a healthcare professional or pharmacist for personalized guidance.

safety information

• warnings: this medicine may increase urination and can contribute to dehydration, low blood pressure, dizziness, and kidney-related issues in susceptible patients. sglt2 inhibitors have been associated with genital fungal infections and urinary tract infections. rare but serious complications, including ketoacidosis with only moderately elevated blood sugar, can occur and may be life-threatening. seek medical help if you develop nausea, vomiting, abdominal pain, unusual fatigue, rapid breathing, or confusion. use caution if you are fasting, severely ill, or recovering from surgery, as these situations can increase the risk of metabolic complications.
• side effects: common side effects may include increased urination, thirst, mild dizziness, urinary tract infection symptoms, genital itching or discharge, nasal congestion, headache, and stomach upset. some patients may experience low blood sugar when this combination is used with insulin or medicines such as sulfonylureas. serious side effects can include severe dehydration, kidney function worsening, severe allergic reactions, pancreatitis, ketoacidosis, and severe infections of the genital or urinary tract.
• precautions: avoid use or use only with strict medical supervision if you have significant kidney disease, recurrent urinary or genital infections, severe dehydration, a history of diabetic ketoacidosis, or frequent episodes of low blood pressure. extra caution is needed in older adults, people on diuretics, and those with a history of low fluid intake. tell your doctor about all current medical conditions, especially liver disease, kidney disease, heart failure, or pancreatic disorders. this medicine is for type 2 diabetes and is not appropriate for type 1 diabetes or diabetic ketoacidosis treatment.
• pregnancy/breastfeeding: the safety of this combination during pregnancy is not well established, and diabetes treatment during pregnancy usually requires individualized care. in general, oral antidiabetic combinations of this type are not preferred during pregnancy unless specifically advised by a specialist. breastfeeding safety is also uncertain, so a physician should decide whether to continue, switch, or stop therapy based on maternal benefits and infant safety.
• interactions: alcohol may increase the risk of dehydration, dizziness, and low blood sugar, especially if food intake is reduced. combining this medicine with insulin or insulin secretagogues can increase hypoglycemia risk and may require closer monitoring. diuretics may increase dehydration risk. medicines that affect kidney function, blood pressure, or fluid balance may also require extra caution. always inform your healthcare professional about all prescription drugs, over-the-counter medicines, and herbal products you use.

additional information

• storage: store in a cool, dry place away from excess heat, moisture, and direct sunlight. keep the tablets in their original packaging until use, and out of reach of children. do not store in a bathroom or near a sink where humidity may damage the medicine.
• missed dose: if you miss a dose, take it as soon as you remember unless it is almost time for the next scheduled dose. if the next dose is near, skip the missed one and return to your regular schedule. do not take two doses at the same time to make up for a missed dose, as this can increase the risk of side effects.
• overdose: an overdose may lead to excessive urination, dehydration, dizziness, weakness, nausea, vomiting, abdominal discomfort, or low blood sugar if other diabetes medicines are involved. severe cases may cause confusion, fainting, or metabolic imbalance. if an overdose is suspected, seek urgent medical attention or contact emergency services immediately.
• habit forming: no. ACTIGLIPT 20mg Tablet is not known to be habit forming or addictive. however, it should not be stopped or changed without medical advice because diabetes control may worsen if treatment is interrupted.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.